sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
19-Dec-2014 16:02
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 851-875 out of 943.

<< < 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 > >>

Public Release: 7-Mar-2013
Study: Computerized reminders significantly improve HIV care in resource-limited setting
A large randomized controlled study led by Regenstrief Institute and Indiana University School of Medicine researchers is among the first to rigorously demonstrate that health information technology can improve compliance with patient care guidelines by clinicians in resource-limited countries.
Abbott Fund, Centers for Disease Control and Prevention

Contact: Cindy Fox Aisen
Indiana University

Public Release: 7-Mar-2013
American Academy of Microbiology releases resistance report
What do cancer cells, weeds, and pathogens have in common? They all evolve resistance to the treatments that are supposed to eliminate them. However, researchers developing the next generation of antibiotics, herbicides, and anti-cancer therapeutics rarely come together to explore the common evolutionary principles at work across their different biological systems.

Contact: Garth Hogan
American Society for Microbiology

Public Release: 5-Mar-2013
5th Regional Pneumococcal Symposium
New study suggests potential shift in burden of pneumococcal disease
New studies revealed today by Latin-American researchers and global health leaders suggest that the highest burden of deadly pneumococcal disease in Latin America may be shifting to adults as countries successfully immunize more infants with new vaccines. The experts called for increased disease monitoring and more surveillance to understand the full extent of pneumococcal disease in the Americas, including its economic impact, and to devise effective strategies to prevent it.
Sabin Vaccine Institute

Contact: Johanna Harvey
Sabin Vaccine Institute

Public Release: 5-Mar-2013
PLOS Medicine
Sharing HIV research findings with participants
Is it feasible to share research findings with HIV-infected participants enrolled in observational research in rural sub-Saharan African? Anna Baylor and colleagues orally disseminated their findings to 477 research participants during a meeting modelled on a traditional wedding event.

Contact: Sumrina Yousufzai

Public Release: 5-Mar-2013
PLOS Medicine
Resistance to first line anti-malarial drugs is increasing on the Thai-Myanmar border
Early diagnosis and treatment with antimalarial drugs (ACTs -- artemisinin based combination treatments) has been linked to a reduction in malaria in the migrant population living on the Thai-Myanmar border, despite evidence of increasing resistance to ACTs in this location, according to a study by international researchers published in this week's PLOS Medicine.

Contact: Sumrina Yousufzai

Public Release: 4-Mar-2013
Vitamin deficiency screening needed for refugees
New research from the University of Adelaide has discovered a high prevalence of vitamin B12 deficiency among refugees, prompting calls for refugees to be routinely screened for the problem soon after they arrive.

Contact: Dr. Jill Benson
University of Adelaide

Public Release: 4-Mar-2013
20th Conference on Retroviruses and Opportunistic Infections
Study of tenofovir vaginal gel shows daily dosing ineffective due to lack of adherence
Researchers with the Microbicide Trials Network today announced results of the Vaginal and Oral Interventions to Control the Epidemic study at the Conference for Retroviruses and Opportunistic Infections in Atlanta, Georgia.

Contact: Annette Larkin

Public Release: 4-Mar-2013
Annals of Internal Medicine
Studies advance knowledge of HIV impact on hepatitis C infection and genes that may thwart HCV
Infectious disease experts at Johns Hopkins have found that among people infected with the hepatitis C virus, co-infection with HIV, speeds damage and scarring of liver tissue by almost a decade.

Contact: David March
Johns Hopkins Medicine

Public Release: 4-Mar-2013
Sanford-Burnham and 60° Pharmaceuticals to pursue promising target for the treatment of dengue fever
Sanford-Burnham Medical Research Institute and 60° Pharmaceuticals have entered into a partnership to test furin, a human proteinase, as a drug target for the treatment of dengue fever, one of the most common infectious diseases in the tropics and subtropics.

Contact: Deborah Robison
Sanford-Burnham Medical Research Institute

Public Release: 4-Mar-2013
New data show countries around the world grappling with changing health challenges
Alzheimer's disease is the fastest growing threat to health in the US. HIV/AIDS and alcohol are severely eroding the health of Russians. Violence is claiming the lives of young men in large swaths of Latin America. Despite health gains in sub-Saharan Africa, infectious diseases still cause hundreds of thousands of child deaths. These findings will be announced on March 5 at the Bill & Melinda Gates Foundation in Seattle, by IHME Director Dr. Christopher Murray and Bill Gates.
Bill & Melinda Gates Foundation

Contact: Rhonda Stewart
Institute for Health Metrics and Evaluation

Public Release: 3-Mar-2013
Nature Climate Change
Early warning system provides 4-month forecast of malaria epidemics in northwest India
Sea surface temperatures in the tropical South Atlantic Ocean can be used to accurately forecast, by up to four months, malaria epidemics thousands of miles away in northwestern India, a University of Michigan theoretical ecologist and her colleagues have found.
National Institute of Malaria Research New Delhi, University of Michigan/Graham Sustainability Institute, NOAA, National Science Foundation, NASA

Contact: Jim Erickson
University of Michigan

Public Release: 28-Feb-2013
Human trials for Streptococcus A vaccine
Griffith University's Institute for Glycomics has launched human trials for a vaccine against Streptococcus A, the germ that causes rheumatic fever.
Queensland Institute of Medical Research

Contact: Helen Wright
Griffith University

Public Release: 28-Feb-2013
Wolf in sheep's clothing: Uncovering how deadly bacteria trick the immune system
A new UCLA study demonstrates how bacteria can pretend to be a virus and trick the immune system into sending out the wrong type of defense. Such manipulation sheds light on how the flu may make us more susceptible to pneumonia or as in the recent outbreak of TB in Los Angeles, possibly how the flu and other environmental factors could be used to the TB bacteria's advantage.
NIH/National Institute of Arthritis and Musculoskeletal Skin Diseases

Contact: Rachel Champeau
University of California - Los Angeles Health Sciences

Public Release: 28-Feb-2013
PLOS Neglected Tropical Diseases
Deworming important for children's health, has limited impact on infection in wider communities
Although they have an important impact on children's health and education, school-based deworming programs have a limited impact on the level of infection in the wider community, according to a mathematical modeling study conducted by researchers at Imperial College London.

Contact: Sam Wong

Public Release: 27-Feb-2013
Rapid, point-of-care tests for syphilis: The future of diagnosis
An international research team, led by the Research Institute of the McGill University Health Centre, has demonstrated that rapid and point-of-care tests (POC) for syphilis are as accurate as conventional laboratory tests. The findings, which were published in PLOS ONE, call for a major change in approach to syphilis testing and recommend replacing first line laboratory tests with POC tests globally, especially in resource-limited settings.
Canadian Institutes of Health Research

Contact: Julie Robert
514-934-1934 x71381
McGill University Health Centre

Public Release: 27-Feb-2013
New study shows viruses can have immune systems
A study published today in Nature reports that a viral predator of the cholera bacteria has stolen the functional immune system of bacteria and is using it against its bacterial host. This provides the first evidence that this type of virus, the bacteriophage, can acquire an adaptive immune system. The study has implications for phage therapy, the use of phages to treat bacterial diseases.
NIH/National Institute of Allergies and Infectious Diseases

Contact: Siobhan Gallagher
Tufts University, Health Sciences Campus

Public Release: 26-Feb-2013
DNDi receives BBVA Foundation award for delivering new treatments for neglected diseases
Today in Madrid, Spain, the Drugs for Neglected Diseases initiative received the BBVA Foundation 'Frontiers of Knowledge and Culture Award for Development Cooperation'. This EUR 400,000 award will be presented at a ceremony in Madrid, Spain, in June of this year.

Contact: Violaine Dällenbach
Drugs for Neglected Diseases Initiative

Public Release: 26-Feb-2013
Breakthrough camera to improve detection of blinding eye disease and diabetes
The world's first intelligent retinal camera will accurately and rapidly detect and eventually diagnose sight-threatening conditions such as diabetic retinopathy and glaucoma. The camera is being designed for ease of use in the most extreme environments so that it can be used by technical support staff and in the most remote and under-served locations, especially to close the gap in eye health in Australian Aboriginal communities.

Contact: Stephen Davis
Brien Holden Vision Institute

Public Release: 26-Feb-2013
PLOS Medicine
Over a million pregnant women infected with syphilis world-wide
Syphilis still affects large numbers of pregnant women world-wide, causing serious health problems and even death to their babies, yet this infection could be prevented by early testing and treatment, according to a study by international researchers published in this week's PLOS Medicine.

Contact: Sumrina Yousufzai

Public Release: 26-Feb-2013
US budget cuts could jeopardize development of life-saving tools against major killers
Across-the-board cuts to US R&D programs could have a devastating impact on efforts to develop new drugs for tuberculosis and HIV/AIDS, the world's first malaria vaccine, and other vital global health products in development, according to a new report from a coalition of nonprofit groups focused on advancing innovation to save lives.

Contact: Katy Lenard
Burness Communications

Public Release: 25-Feb-2013
Cell Reports
Putting malaria on the SHELPH
Experts have disabled a unique member of the signalling proteins which are essential for the development of the malaria parasite. They have produced a mutant lacking the ancient bacterial Shewanella-like protein phosphatase known as SHLP1 (pronounced shelph). This mutant is unable to complete its complex life cycle and is arrested in its development in the mosquito.
MRC, Wellcome Trust

Contact: Lindsay Brooke
University of Nottingham

Public Release: 25-Feb-2013
Proceedings of the National Academy of Sciences
Scientists' findings disclose a new and much needed test for river blindness infection
Scientists at the Scripps Research Institute have found a telltale molecular marker for onchocerciasis or "river blindness," a parasitic infection that affects tens of millions of people in Africa, Latin America and other tropical regions. The newly discovered biomarker, detectable in patients' urine, is secreted by Onchocerca volvulus worms during an active infection. The biomarker could form the basis of a portable, field-ready test with significant advantages over current diagnostic methods.
Worm Institute of Research and Medicine at Scripps Research Institute

Contact: Mika Ono
Scripps Research Institute

Public Release: 21-Feb-2013
Dissertations and Features
Same-sex attracted men neglected in Africa
HIV-related research and programming has excluded same-sex attracted men in Africa for three decades. Their exclusion cannot be accounted for by the assertion that they are unreachable, says Norwegian researcher.

Contact: Thomas Keilman
The Research Council of Norway

Public Release: 21-Feb-2013
Scale-up of HIV treatment in rural South Africa dramatically increases adult life expectancy
The large antiretroviral treatment scale-up in a rural community in KwaZulu-Natal, South Africa, has led to a rapid and dramatic increase in population adult life expectancy.
Wellcome Trust, National Institutes of Health

Contact: Todd Datz
Harvard School of Public Health

Public Release: 21-Feb-2013
Research suggests malaria can be defeated without a globally led eradication program
Malaria does not have to be eradicated globally for individual countries to succeed at maintaining elimination of the disease, according to research from the University of Florida's Emerging Pathogens Institute and department of geography, to be published in the journal Science Feb. 22.

Contact: Andrew Tatem
University of Florida

Showing releases 851-875 out of 943.

<< < 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 > >>